How can you get the most out of your KOL roundtable? With ever more communication tools available, Genevieve Robson provides some top tips to ensure your KOL meetings have maximum impact.
Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback